Our New Venture- Pharmaceutical
Metabolic Disorders today is slowly becoming an epidemic and India today is poised to becoming the Metabolic Disorder Capital of the World. Blood Pressure, Cholesterol & Diabetes are the three major Silent Killers affecting other major organ damage. Lack of awareness, diagnosis and proper healthcare management systems increases the risk of morbidity and mortality.
SKM Group, already having recognizable presence in healthcare industry in eastern India, now ventures into the pharmaceutical industry with Vitabolik Pharmaceutucals Pvt Ltd, focusing on the above disease and therapies. With the vision of becoming a trusted and admirable partner to the society in treating metabolic disorders, VBPPL offers therapies for blood pressure, cholesterol, heart failure, diabetes, nerve disorders and sexual dysfunction.
Currently the company will start its phase -1 operation in West Bengal and Delhi, followed by phase -2 operations in Mumbai, Rajasthan and North-East and finally expand to All India by 2019.
VBPPL strictly believes in Quality of its products and our brands are manufactured in facilities having WHO-cGMP certification.
VBPPL strongly believes in educating people, creating awareness & screening for metabolic disorders. We will be conducting “SPANDAN – The Rhythm Of Life” programs in association with various societies and organizations so that TOGETHER WE HEAL INDIA AND MAKE IT A BETTER PLACE FOR ALL…